A Pillar of Heart Attack Treatment Shaken: What's Next? The recent findings from the REBOOT Trial have sent shockwaves through the medical community, challenging a 40 year standard in heart attack treatment.
Beta blockers, long considered a cornerstone of cardiac care after uncomplicated myocardial infarction, may not offer any real benefit for patients whose heart function remains normal.
Beta blockers were introduced in the 1980s as part of modern cardiac care's early development. At that time, coronary artery blockages often went untreated until they had caused significant damage to the heart muscle.